These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1246006)

  • 61. [Pharmacological action of eptazocine (l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benzazonine). Effects of eptazocine on spontaneous movements].
    Sakakibara S
    Nihon Yakurigaku Zasshi; 1983 Jun; 81(6):549-63. PubMed ID: 6618345
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of the discriminative stimulus properties of nefopam and morphine.
    Frey LG; Winter JC
    Psychopharmacology (Berl); 1979 Mar; 61(2):231-2. PubMed ID: 108741
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Morphine effects upon discriminated approach and discriminated avoidance in rats: antagonism by naloxone.
    Babbini M; Gaiardi M; Bartoletti M
    Psychopharmacology (Berl); 1980; 70(1):73-7. PubMed ID: 6775339
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Brief communication. Generalization of [DAla2]-enkephalinamide but not of substance P to the morphine cue.
    Chipkin RE; Stewart JM; Morris DH; Crowley TJ
    Pharmacol Biochem Behav; 1978 Jul; 9(1):129-32. PubMed ID: 704649
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Flunixin meglumine: a non-narcotic analgesic.
    Ciofalo VB; Latranyi MB; Patel JB; Taber RI
    J Pharmacol Exp Ther; 1977 Mar; 200(3):501-7. PubMed ID: 850126
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Factors regulating drug cue sensitivity: the effect of frustrative non-reward in fentanyl-saline discrimination.
    Colpaert FC; Janssen PA
    Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):241-51. PubMed ID: 6461303
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The peripheral analgesic effect of morphine, codeine, pentazocine and d-propoxyphene.
    Molina N; Vettore O; Lorenzetti BB; Ferreira SH
    Braz J Med Biol Res; 1983 Dec; 16(4):345-52. PubMed ID: 6673813
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacological study of pentazocine-naloxone combination: interest as a potentially non abusable oral form of pentazocine.
    Legros J; Khalili-Varasteh H; Margetts G
    Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):11-21. PubMed ID: 6541897
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of conditioned reinforcers in the initiation, maintenance and extinction of drug-seeking behavior.
    Davis WM; Smith SG
    Pavlov J Biol Sci; 1976; 11(4):222-36. PubMed ID: 1033507
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Discriminative stimulus properties of the mixed agonist-antagonist pentazocine in the rat using two-choice discrete-trial avoidance paradigm.
    Ukai M; Nakayama S; Hamada T; Kameyama T
    Pharmacol Biochem Behav; 1989 Jun; 33(2):355-9. PubMed ID: 2813473
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Electroencephalographic study of pentazocine and buprenorphine.
    Kubicki S; Azcona A
    Acta Anaesthesiol Belg; 1979; 30 Suppl():123-33. PubMed ID: 547656
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effects of meptazinol in comparison with pentazocine, morphine and naloxone in a rat model of anaphylactic shock.
    Paciorek PM; Todd MH; Waterfall JF
    Br J Pharmacol; 1985 Feb; 84(2):469-75. PubMed ID: 3978318
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evidence supporting lack of discriminative stimulus properties of a combination of naltrexone and morphine.
    Järbe TU; Loman P; Swedberg MD
    Pharmacol Biochem Behav; 1979 Apr; 10(4):493-7. PubMed ID: 461479
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lack of blockade of central dopaminergic receptors by narcotics: comparison with chlorpromazine.
    Schechter MD
    Eur J Pharmacol; 1978 Jun; 49(3):279-84. PubMed ID: 658141
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of loperamide, haloperidol and methadone in rats trained to discriminate morphine from saline.
    Gianutsos G; Lal H
    Psychopharmacologia; 1975; 41(3):267-70. PubMed ID: 1153614
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Discriminative stimulus properties of naloxone.
    Carter RB; Leander JD
    Psychopharmacology (Berl); 1982; 77(4):305-8. PubMed ID: 6291084
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Naloxone decreases responding for conditioned reinforcement in rats.
    Rudski J
    Psychol Rep; 2007 Feb; 100(1):263-9. PubMed ID: 17451034
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interactions between H1-antagonists and opioids: a drug discrimination study.
    Suzuki T; Mori T; Tsuji M; Misawa M; Onodera K
    Psychopharmacology (Berl); 1997 Jun; 131(4):346-53. PubMed ID: 9226736
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gamma-butyrolactone's discriminability and effect on low rates of lever pressing by rats: alone and in combination with D-amphetamine and naloxone.
    McIntire KD; Cleary J; Weinfurter S
    Pharmacol Biochem Behav; 1988 May; 30(1):45-53. PubMed ID: 3174754
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of d-amphetamine, morphine, naloxone, and drug combinations on visual discrimination in rats.
    Andrews JS; Holtzman SG
    Psychopharmacology (Berl); 1988; 94(2):172-7. PubMed ID: 3127842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.